Market Research Blog

Fluorescence-Activated Cell Sorting Market: Overview 

Global Fluorescence-Activated Cell Sorting market has witnessed growth due to expanding demand for flow cytometry testing for several diseases like cancer and HIV/AIDS. Fluorescence-Activated Cell Sorting is extensively being performed for clinical purposes, like it is being used for several novel drug discoveries. Fluorescence-Activated Cell Sorting is highly useful for stem cell technology researches and is efficiently being used for different diagnostic purposes as well.  Fluorescence-Activated Cell Sorting has tremendous application in immunology and cancer researches. Increase in cancer researches is expected to drive the research institute segment, by application type for Fluorescence-Activated Cell Sorting market.

Flow cytometry is a procedure that analyzes chemical and physical characteristics of certain particles in a fluid while passing through at least one laser. These cell components are labelled with fluorescence and when laser is passed, these cell components emit light at various wavelengths. Fluorescence-Activated Cell Sorting is an advanced type of flow cytometry which is used for sorting heterogeneous mixture of living cells based on light scattering properties and fluorescent labelling of the cells. The suspension of these cells is contained in a rapidly moving, narrow liquid stream, through which vibration caused the liquid stream to break in single droplets. Prior the vibration, liquid stream is passed through one or more laser beams which further allows the fluorescence pattern of individual cell to be identified. This liquid stream is further broken into droplets depending upon the characteristics chosen from the initial fluorescence analysis. These droplets then pass via an array of electrostatic deflectors. These deflectors divert the droplets in wells or test tubes according to their charge.

Fluorescence-Activated Cell Sorting Market: Drivers and Restraints-

Growing incidence of chronic diseases like cancer and HIV/AIDS is highly responsible for driving the market for Fluorescence-Activated Cell Sorting. Growing demand for cancer therapies, rise in geriatric population, and increased adoption of cell sorting with easy availability of flow cytometry in all the diagnostic centers and clinics are few of the major factors that are expected to drive the market growth for Fluorescence-Activated Cell Sorting. Certain government initiatives funding the cell therapy researches and flow cytometry studies might also boost the Fluorescence-Activated Cell Sorting market during the forecast period. However, the device cost is extremely high and there are several alternatives for the procedure, which might hinder the market growth for Fluorescence-Activated Cell Sorting. Several stringent regulations and requirement of skilled professional to perform Fluorescence-Activated Cell Sorting could also be the factors that might prove to be major restraints for Fluorescence-Activated Cell Sorting market during the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-8025

Fluorescence-Activated Cell Sorting Market: Region-wise Outlook

Geography wise, Fluorescence-Activated Cell Sorting market is divided into eight regions viz. North-America, Asia- Pacific excluding China & Japan, China, Japan, Western Europe, Eastern Europe, Latin America and Middle-East & Africa. Europe’s Fluorescence-Activated Cell Sorting market is also expected to grow at a significant rate due to increased availability of Fluorescence-Activated Cell Sorting kits and rise in number of diagnostic centers in the region. North America’s Fluorescence-Activated Cell Sorting market is expanding because of improved adoption rate of flow cytometry and it is expected to grow at a robust growth rate during the period of forecast due to growing number of research facilities and increased funding by the government for the research studies. Asia-Pacific’s Fluorescence-Activated Cell Sorting market and Middle East and Africa’s Fluorescence-Activated Cell Sorting market are anticipated to grow at a decent rate due to less number of healthcare facilities.

Fluorescence-Activated Cell Sorting Market: Key Market Participants

Some of the market participants in the Global Fluorescence-Activated Cell Sorting market identified across the value chain include: Bio-Rad Laboratories, Inc., Merck KGaA, Thermo Fisher Scientific Inc., Bio-Techne, BD, Miltenyi Biotec GmbH, Sony Biotechnology Inc., Cytonome/ST, LLC, Danaher Corporation, Sysmex Partec GmbH, Terumo BCT, Inc., Union Biometrica, Inc, STEMCELL Technologies Inc., On-Chip Biotechnologies Co., Ltd., and pluriSelect Life Science UG & Co.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (India, ASEAN, Australia & New Zealand)
• China
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8025

Fluorescence-Activated Cell Sorting Market: Segmentation 

On the basis of Application, Fluorescence-Activated Cell Sorting Market can be segmented as:

• Research Applications of Fluorescence-Activated Cell Sorting
• Virology
• Immunology and Cancer Research
• Clinical Chemistry
• Drug Delivery
• Others
• Clinical Applications of Fluorescence-Activated Cell Sorting

On the basis of End User, Fluorescence-Activated Cell Sorting Market can be segmented as:

• Research Institutes
• Diagnostic Centers
• Hospitals
• Clinics
• Laboratories

On the basis of geography, Fluorescence-Activated Cell Sorting Market can be segmented as:

• North- America
• Eastern Europe
• Western Europe
• Asia-Pacific excluding China & Japan
• China
• Japan
• Middle East and Africa
• Latin America

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Retinoids market is anticipated to grow with a significant growth rate over the forecast period 2018-2028. Retinoids are generally prescribed by dermatologists for mild to moderate acne. Retinoids generally come in three different forms: cream, gels, and liquid. These form of retinoids result in reduced keratinization and proliferation of skin cells. Based on the distribution channel, retinoids market is segmented into retail pharmacies, hospital pharmacies, drug stores, e-commerce, and others. Others distribution channel include supermarkets & hypermarkets and drug stores. Retinoids can be obtained over the counter at supermarkets and pharmacies. 

More than two decades ago, retinoids have been extensively used for the treatment of acne, skin aging, psoriasis, and certain types of cancer. Retinoids are a class of medications which are chemically derived from vitamin A. Retinoids regulate several transcription factors like RXR and RAR located within the nucleus of various cells. Today a variety of retinoids are available in the market: retinol, adapalene, tretinoin, tazarotene, bexarotene, and alitretinoin. The retinoids come in gel, cream, and liquid forms. Tretinoin is considered the most effective and certainly the most widely investigated retinoid for photo aging therapy.  Tretinoin was the first retinoid approved by the FDA to treat wrinkles. Retinoids slower the growth of skin cells in patients suffering from psoriasis. Retinoids reduce the inflammation and restore the normal epidermal differentiation that is absent in psoriatic lesions. Retinoids are very helpful for many common skin problems but are not without risks like dryness and irritation, changes in skin color, redness, blistering, swelling, and others. Furthermore, retinoids are also used for the treatment of pigmentary disorders like post-inflammatory hyperpigmentation, actinic lentiginous, and melasma.

Retinoids Market: Drivers and Restraints

The increasing burden associated with acne leads patients to seek professional help in the form of prescription treatments. This is further expected to boost the growth of the global retinoids market. Increasing demand for minimally invasive treatment procedure is also driving the growth of the global retinoids market. It is observed that the dermatologists prefer to treat skin problems through less invasive procedures or the use of topical applications compared with surgical methods. Irritant reactions such as scaling, burning, or dermatitis related with the retinoid therapy may limit their acceptance among the end users which is expected to hamper the growth of the global retinoids market. Furthermore, in order to minimize the side effects caused due to retinoids, people are opting for alternative therapies which are also expected to hamper the growth of the global retinoids market. In order to reduce these side effects, numerous new drug delivery systems have been developed. For instance, nanoparticles have shown a noble potential in improving the tolerability, stability, and efficacy of retinoids like retinol and tretinoin.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-8060

Retinoids Market: Regional Outlook

On the basis of geography, the global retinoids market is segmented into eight key regions, namely North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding China, and Japan, China, Japan, and Middle East & Africa. North America retinoids market is expected to hold maximum market share in the global retinoids market owing to the presence of established market players. Asia Pacific retinoids market is anticipated to grow at a rapid pace with the maximum CAGR over the forecast period due to rising healthcare facilities in the region. However, the retinoids market in low middle-income countries like Latin America, and the Middle East and Africa is anticipated to show a slow growth over the forecast period due to lack of awareness and trained healthcare professionals.

Retinoids Market: Key Players

Some of the key players in the global retinoids market are Mylan N.V., Ion Labs Inc., Bausch Health Companies Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche AG, and others. The established players in the retinoids market are majorly focusing to adopt both organic and inorganic strategies in order to gain more market share in the global retinoids market. Medium sized market players are expanding their geographical presence to increase their market presence in the global retinoids market.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
• China
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8060

Retinoids Market: Segmentation 

The global retinoids market is segmented by retinoids form type, distribution channel and region:

Based on retinoids form type, the global retinoids market is segmented into:

• Cream
• Gel
• Liquid

Based on distribution channel, the global retinoids market is segmented into:

• Hospital Pharmacies
• Retail Pharmacies
• e-commerce
• Others

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Growing usage of various meats in Western diet together with increasing adoption of the Western eating habits throughout the globe is expected to stimulate demand supply for animal antibiotics and antimicrobials market.

Investments in Biosecurity to Curb Animal Diseases

Animal diseases for instance, African swine fever or avian influenza are increasing day after day, thereby affecting new areas as well. Therefore, reducing probable risks by means of implementing procedures developed for avoiding spread and introduction of pathogens in the animal population is expected to create lucrative growth opportunities for animal antibiotics and antimicrobials market. Heavy efforts have been taken by veterinary services to enter into collaboration with various stakeholders, thereby developing appropriate biosecurity measures, positively impacting on the development of animal antibiotics and antimicrobials market. OIE Regional Commission for Europe is planning to implement biosecurity plans for enhancing biosecurity in the non-commercial and backyard farms as well, thereby preventing spread of diseases. Growing measures taken to prevent spread of the animal diseases is further expected to contribute towards the growth of animal antibiotics and antimicrobials market.

Rising Pet Health Insurance and Animal Healthcare Expenditure Boosts Sales

Increasing pet insurance is mainly attributed towards surging cost of the veterinary services and treatments. However, growing veterinary expenditure and increasing number of veterinary visits are expected to dive in significant opportunities for animal antibiotics and antimicrobials market growth. Increasing ownership of the companion animals has led to surging number of veterinary orthopedic treatment, which in turn drives demand supply in animal antibiotics and antimicrobials market. Growing obesity cases in the pets are significantly contributing towards stimulated animal healthcare expenditure, thereby impacting on the growth and development of animal antibiotics and antimicrobials market in the long run.

Fluoroquinolones Gain Prominence

Fluoroquinolones is expected to witness growing demand in animal antibiotics and antimicrobials market owing to its high-efficiency at low concentration, diversified route of administration and quicker penetration through tissues. However, increasing number of stringent regulations regarding the usage of fluoroquinolones is likely to impact on the revenue sales in animal antibiotics and antimicrobials market in the forthcoming years. Recently, FDA has approved class-wise labelling changes for the entire fluoroquinolone antibiotics product portfolio, in order to strengthen the threats related to the mental health side-effects as well as risks for acute low blood sugar, which is inclusive of hypoglycemic coma.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-8065

North America to Showcase Impressive Growth

Growing incidences of outbreak of the animal diseases, high ownership cases of companion animals and excessive livestock products consumption is contributing towards the notable growth of North America animal antibiotics and antimicrobials market. In addition, key players in the region are taking immense efforts in making huge investments for introducing drugs that would cater to the treatment of animal diseases. Nash Pharma, recently introduced two potential compounds, which statistically and substantially improved various diseases related endpoints with regards to ulcerative colitis models compared to the untreated animals. All these factors are expected to prove significantly beneficial for the region’s animal antibiotics and antimicrobials market growth.

New Launches by Key Players

Need for commercial-ready products are witnessed as significantly influencing the manufacturers in animal antibiotics and antimicrobials market. Animal health giants have been striving for outsourcing innovation to the hungry start-ups with the help of collaborations as well, thereby revolutionizing future of the animal health.

• Bayer AG: The animal antibiotics and antimicrobials market player recently launched i-COWNT BRD, which is an innovative digital comparison tool benefitting veterinarians in making more informed treatment choices for the bovine respiratory disease. This innovative tool is expected to contribute significantly towards improving treatment outcomes, promoting cattle well-being and health as well as majorly contributes in responsible usage of antibiotic use. This in turn offers lucrative development opportunities for the manufacturers in animal antibiotics and antimicrobials market for the upcoming years, thereby supporting them with expansion of global presence.
• Boehringer Ingelheim: The animal antibiotics and antimicrobials market player lately introduced ‘LastMile’ initiative, which is a solution-driven and integrated program that helps in catering to the critical animal health challenges, thereby developing consistent availability of the animal medical resources across the hard-to-reach areas. Most of all, the initiative is mainly targeted towards food-producing animals such as cattle, sheep and goats and is likely to further expand with inclusion of poultry as well. All these factors are expected to create revenue sales growth avenues for animal antibiotics and antimicrobials market.

Wide-Ranging Study on Animal Antibiotics and Antimicrobials Market Research Report Covers:

• Value chain
• Technological developments
• Market participants and competition
• Trends and challenges currently impacting global market
• Demand and sales
• Market sizing
• Growth prospects
• Segmentation

Country-Wise Analysis in Animal Antibiotics and Antimicrobials Market Research Report Is Done On The Basis Of:

• North America animal antibiotics and antimicrobials market including (Canada and U.S.)
• Latin America animal antibiotics and antimicrobials market including (Brazil and Mexico)
• Eastern Europe animal antibiotics and antimicrobials market including (Russia and Poland)
• Western Europe animal antibiotics and antimicrobials market including (Spain, U.K., France, Italy and Germany)
• Asia Pacific animal antibiotics and antimicrobials market including (New Zealand, Australia, ASEAN, India and China)
• Japan animal antibiotics and antimicrobials market
• Middle East and Africa animal antibiotics and antimicrobials market including (North Africa, South Africa and GCC Countries)

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8065

Classification of Animal Antibiotics and Antimicrobials Market Is Done By Animal Type, Mode of Delivery and Product

A Microplate is a flat plate that has many wells on it. These wells serve as small test tubes in clinical and analytical diagnostic testing laboratories. Automated microplate handling systems are used to handle these microplates during any medical diagnostic or analytical procedure. Automated microplate handling systems are extensively used in enzyme-linked immunosorbent assay procedures also known as ELISA. Manual microplate handling systems are more prone to human-induced errors and are labour intensive. These handling systems are used in high-throughput protocols in which the microtiter plates are designed to move around a work cell, place or remove them from microplate nests and microplate stacks of other devices like, incubators, microplate readers and liquid handlers. Automated microplate handling systems work seamlessly with different molecular devices for higher throughput and improved process flow. These systems allow analysts to speed up and control range of processes. These are also tremendously used in cellular analysis, next generation sequencing, serial dilution, PCR set-up, plate labelling, toxicology etc.

Automated Microplate Handling Systems Market: Drivers and Restraints-

Consistent rise in need for high and ultra-high throughput screening is one of the major factors driving the automated microplate handling systems market during the forecast period. Growing researches for next generation sequencing, increase in procedures like polymerase chain reaction and cellular analysis, is also expected to boost the market growth for automated microplate handling systems. Automated systems reduce errors and reduce time-to-market for drugs, which might also drive the market growth for automated microplate handling systems during the forecast period. However, less availability and popularity of these automated microplate handling systems might hinder the market. Preferring manual labour over automation could also affect the automated microplate handling systems market over the forecast period.

Automated Microplate Handling Systems Market: Region-wise Outlook 

Geography wise, Automated Microplate Handling Systems market is divided into eight regions viz. North-America, Asia- Pacific excluding China & Japan, China, Japan, Western Europe, Eastern Europe, Latin America and Middle-East & Africa. North America’s Automated Microplate Handling Systems market is expanding because of high investments by the government for developing technologically advanced diagnostic and research technologies and it is expected to remain dominant over the period of forecast due easy availability and high rate of adoption for these novel technologies. North America’s Automated Microplate Handling Systems market is also expected to grow the fastest due to high prevalence of chronic and infectious diseases requiring advanced diagnosis. Asia-Pacific Automated Microplate Handling Systems market is anticipated to grow at a decent rate due to growing awareness on Automated Microplate Handling Systems, its advantages over manual handling and expanding biotechnology industry in the region.

Automated Microplate Handling Systems Market: Key Market Participants

Some of the market participants in the Global Automated Microplate Handling Systems market identified across the value chain include:Bio-Rad Laboratories, Inc, Hudson Robotics, Avantor, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Danaher, PerkinElmer Inc., Corning Incorporated, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. And Lonza.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-8101

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (India, ASEAN, Australia & New Zealand)
• China
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Automated Microplate Handling Systems Market: Segmentation 

On the basis of Well Size, Automated Microplate Handling Systems Market can be segmented as:

• 45 wells
• 96 wells
• 384 wells
• 1,536 wells
• Others

On the basis of Use Type, Automated Microplate Handling Systems Market can be segmented as:

• Pipetting
• Centrifugation
• Liquid dispensing
• Pre-Transfusion
• Others

On the basis of Application Type, Automated Microplate Handling Systems Market can be segmented as:

• Polymerase Chain Reaction
• Next-Generation Sequencing
• In-Vitro Diagnostics
• Cellular Analysis
• Others

On the basis of end users, Automated Microplate Handling Systems Market can be segmented as:

• Hospitals
• Research Institutes
• Diagnostic Centers
• Others

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8101

On the basis of geography, Automated Microplate Handling Systems Market can be segmented as:

• North- America
• Eastern Europe
• Western Europe
• Asia-Pacific excluding China & Japan
• China
• Japan
• Middle East and Africa
• Latin America

[212 Pages Report] Currently heading towards a market value of over US$ 440 Mn, the global market for 3D printed medical devices is projected for stupendous growth at 16% CAGR during 2022- 2029. North America will remain the leading market for 3D printed medical device sales, whereas the market attractiveness of Asia Pacific has been rising notably.

The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

Key Takeaways – 3D Printed Medical Devices Market Study

• Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.
• PolyJet – InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.
• Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.
• The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

Asia Pacific has become the global hub of opportunities, and the leaders in 3D printed medical devices landscape have been eying the opportunity here – owing to the massive application scope, remarkably growing patient population, and relatively less manufacturing costs.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1501

Who Is Winning?

Until late 2016, the key focus of most leading players in the 3D printed medical devices market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.

The focuse is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

Learn More About Report Inclusions

Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022 – 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet – inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

Key Market Segments Covered in 3D Printed Medical Devices Industry ResearchBy Application : 

• Orthopaedic Implants
• Dental Implants
• Cranio-maxillofacial Implants
• Internal and External Prostheses

By Technology :

• Stereolithography (SLA) – Liquid Based 3D Printing
• Selective Layer Sintering (SLS) – Powder Based 3D Printing
• Digital Light Processing(DLP)
• Fused Deposition Modeling (FDM): Plastic Filament Extrusion Based
• PolyJet / InkJet 3D Printing
• Electronic Beam Melting (EBM)

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1501

By Distribution Channel :

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

By Material :

• Plastics
  • Thermoplastics
  • Photopolymers
• Biomaterial Inks
  • Polymers
  • Ceramics
  • Hydrogels
• Metals and Alloys

By Region :

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East & Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1501

[317 Pages Report] A new market research report by Future Market Insights on the pressure infusion bags market includes global industry analysis 2014 – 2021 and opportunity assessment 2022 – 2029. The report investigates the pressure infusion bags market and provides critical insights for the forecast period of 2022 -2029.

As per the findings of the report, the global pressure infusion bags market is projected to experience significant growth over the forecast period due to multiple driving factors such as increasing emergency and transfusion cases and development of healthcare infrastructure across geographies.

The global pressure infusion bags market was valued at ~US$ 300 Mn in 2021, and is expected to increase at a CAGR of ~6.5% during the forecast period of 2022-2029. This growth is majorly driven by the increasing use of pressure infusion bags for rapid infusion of blood and drugs, in order to protect the end organ damage during traumatic conditions.

The overall progress of the healthcare sector and infrastructure in MEA and Asia-Pacific are likely to unfold lucrative opportunities for market players operating in the pressure infusion bags market. In addition, manufacturers are expected to primarily focus on developing cost-effective and user-friendly bags in the coming years. 

South Asia Continues to Hold Lucrative Opportunities

Regions such as North America and East Asia are expected to hold prominent market shares in terms of value. However, the South Asia market is expected to project lucrative growth in the global pressure infusion bags market over the forecast period of 2022-2029.

This growth is propelled by the rapid growth and development of healthcare infrastructure, especially trauma care units, intensive care units and ambulatory surgical centers in countries of South Asia that include India and ASEAN countries. The economic condition of these countries have been developing positively, thereby creating newer growth opportunities for the market players.

Macroeconomic factors such as growing population, increasing immunosuppressed patient population, and increase in the number of players along with strong distribution network and rapid development in the healthcare infrastructure have attracted the attention of manufactures to establish a firm collaboration with local distributors in South Asia.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2243

Hospitals and Outpatient Facilities Remain Key End Users for Pressure Infusion Bags

The global market of pressure infusion bags has been segmented on the basis of different types of pressure infusion bags products, their multiple applications, their volume capacity, their material, their targeted indications and regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East and Africa.

• By type, the disposable type of pressure infusion bags segment is expected to hold prominent value shares of the global pressure infusion bags market. This has majorly resulted to avoid and minimizing chances of cross contamination during fluid infusion and ensures the patient safety
• On the basis of application, the blood and drug infusion segment is expected to consume majority share of the global pressure infusion bags market value. Invasive Pressure monitoring procedures is the second application which account the remaining market share.

Pressure Infusion Bags Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global pressure infusion bags market. Some of the examples of key players in the global pressure infusion bags market are VBM Medizintechnik GmbH, ERKA, Smiths Medical (Smiths Group plc.), Friedrich Bosch GmbH & Co. KG, Biegler GmbH, SARSTEDT AG & Co. KG. Vyaire Medical Inc., Spengler SAS, Armstrong Medical, SunMed and Statcorp Medical

Pressure Infusion Bags Market by Category

By Product:

• Reusable Pressure Infusion Bags
• Disposable Pressure Infusion Bags

By Material:

• Nylon
• Polyurethane
• Latex
• Others

By Capacity:

• 500cc
• 1000cc
• 3000cc
• Above 3000cc

 By Application:

• Blood & Drug Infusion
• Invasive Pressure Monitoring Procedure

By Indications:

• Trauma-Induced Haemorrhage
• Obstetric Haemorrhage
• Coagulopathy during cardiopulmonary bypass

By End User:

• Hospitals
• Out-patient facilities
• Clinics
• Long-term care centers

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2243

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

[199 Pages Report] Driven by the demand for efficient medical laboratory equipment and the changing face of healthcare models, the global market for vacuum mixing devices – valued at ~ US$ 154.0 Mn in 2021 – is estimated to grow by ~ 2% YOY in 2022. These insights are according to a new research report by Future Market Insights (FMI), which underlines the key headwinds and tailwinds determining the future potential of vacuum mixing devices market.

Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period (2016 – 2026).